HUNT RONALD
SEC insider (Form 3/4/5 filer). CIK 0001247851. Director at Rallybio Corp (RLYB) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 18, 2026. Located in NEW HAVEN, CT.
Companies HUNT RONALD has filed insider reports for
- Rallybio Corp (RLYB): Director
- Iterum Therapeutics plc (ITRM): Director
HUNT RONALD
CIK: 0001247851
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 18, 2026RLYB
Rallybio Corp
AwardDirectOption (Right to Buy)
14.3K shares at avg. $3.60- - May 13, 2025RLYB
Rallybio Corp
AwardDirectOption (Right to Buy)
28.5K shares- - Jan 13, 2025ITRM
Iterum Therapeutics plc
OtherIndirect6.500% Exchangeable Senior Subordinated Note due 2025
0 shares at avg. $2208000.00- - Jan 13, 2025ITRM
Iterum Therapeutics plc
OtherIndirect6.500% Exchangeable Senior Subordinated Note due 2025
0 shares at avg. $792000.00- - Jan 2, 2025RLYB
Rallybio Corp
AwardDirectOption (Right to Buy)
73.6K shares at avg. $0.70-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 18, 2026 |  RLYB Rallybio Corp | Award Option (Right to Buy) | 14,305 | $3.60 | - | Direct |
| May 13, 2025 | RLYB Rallybio Corp | Award Option (Right to Buy) | 28,500 | - | - | Direct |
| Jan 13, 2025 |  ITRM Iterum Therapeutics plc | Other 6.500% Exchangeable Senior Subordinated Note due 2025 | 0 | $2208000.00 | - | Indirect |
| Jan 13, 2025 | ITRM Iterum Therapeutics plc | Other 6.500% Exchangeable Senior Subordinated Note due 2025 | 0 | $792000.00 | - | Indirect |
| Jan 2, 2025 | RLYB Rallybio Corp | Award Option (Right to Buy) | 73,571 | $0.70 | - | Direct |
1-5 of 5 transactions